Firefly Neuroscience (AIFF) Capital Expenditures (2010 - 2026)
Firefly Neuroscience (AIFF) posted Capital Expenditures of $42000.0 for Q2 2026, down 27.59% on a QoQ basis from $58000.0 in Q1 2026, and up 250.0% year-over-year from $12000.0 in Q2 2025.
Powered by 
Analysis
Firefly Neuroscience (AIFF) Capital Expenditures (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported Capital Expenditures for 16 years, with the latest figure at $42000.0 in Q2 2026.
- On a quarterly basis, Capital Expenditures rose 250.0% year-over-year to $42000.0 in Q2 2026; TTM through Jun 2026 was $209000.0, a 38.41% increase from a year earlier, with the FY2025 full-year figure at $128000.0, down 13.51% from the prior year.
- Capital Expenditures was $42000.0 for Q2 2026 at Firefly Neuroscience, down from $58000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $301842.0 in Q4 2022, with the low at $7000.0 in Q1 2025.
- Average Capital Expenditures over 4 years is $74658.5, with a median of $50000.0 recorded in 2026.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures jumped 2096.17% in 2022, then slumped 81.25% in 2025.
- Over 4 years, Capital Expenditures stood at $301842.0 in 2022, then sank by 77.47% to $68000.0 in 2024, then sank by 66.18% to $23000.0 in 2025, then soared by 82.61% to $42000.0 in 2026.
- The last three Capital Expenditures figures came in at $42000.0 (Q2 2026), $58000.0 (Q1 2026), and $23000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 100.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 2.34 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 4.00 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 974,000.00 |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 25.50 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 17,000.00 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 9.00 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | 42,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Sep 30, 2025 | 86,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Dec 31, 2022 | 301,842.00 |
| Sep 30, 2022 | 203,027.00 |
| Jun 30, 2022 | 19,260.00 |
| Mar 31, 2022 | 11,773.00 |
| Dec 31, 2021 | 13,744.00 |
| Sep 30, 2021 | 33,556.00 |
| Jun 30, 2021 | 17,842.00 |
| Mar 31, 2021 | 4,612.00 |
| Dec 31, 2020 | 5,907.00 |
| Sep 30, 2020 | 49,843.00 |
| Dec 31, 2019 | 1,035.00 |
| Sep 30, 2019 | 1,368.00 |